Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRCP | P42785 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | CPB1 | P15086 | 1/20 | 0.43 |
| ▸ | PREP | P48147 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | FKBP1A | P62942 | 5/20 | 0.41 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17335883 | 1.00 | PRCP (0.54) | PRCPSMN1; SMN2KMT2ATSHRCYP3A4 | |
| SCHEMBL18875526 | 0.92 | PRCP (0.55) | PRCPSMN1; SMN2KMT2ATSHRCYP3A4 | |
| SCHEMBL17335884 | 0.92 | PRCP (0.54) | PRCPSMN1; SMN2KMT2ATSHRCYP3A4 | |
| SCHEMBL17335885 | 0.92 | PRCP (0.54) | PRCPSMN1; SMN2KMT2ATSHRCYP3A4 | |
| SCHEMBL18863404 | 0.87 | PRCP (0.53) | PRCPSMN1; SMN2KMT2ATSHRCYP3A4 | |
| SCHEMBL18863403 | 0.87 | PRCP (0.53) | PRCPSMN1; SMN2KMT2ATSHRCYP3A4 | |
| SCHEMBL18875712 | 0.85 | PRCP (0.51) | PRCPSMN1; SMN2KMT2ATSHRCYP3A4 | |
| SCHEMBL17335905 | 0.83 | PRCP (0.53) | PRCPSMN1; SMN2KMT2ATSHRCYP3A4 | |
| SCHEMBL17335904 | 0.83 | PRCP (0.53) | PRCPSMN1; SMN2KMT2ATSHRCYP3A4 | |
| SCHEMBL17335929 | 0.82 | PRCP (0.61) | PRCPSMN1; SMN2KMT2ATSHRCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3155436-B1 | ISOBARIC MASS LABELS | ELECTROPHORETICS LTD (GB) | 2023-08-30 | — | — | EP | disclosed |
| US-20170146549-A1 | ISOBARIC MASS LABELS | ELECTROPHORETICS LIMITED (GB) | 2017-05-25 | — | — | US | disclosed |
| EP-3155436-A1 | ISOBARIC MASS LABELS | Electrophoretics Limited (GB) | 2017-04-19 | — | — | EP | disclosed |
| WO-2015189413-A1 | ISOBARIC MASS LABELS | ELECTROPHORETICS LIMITED (GB) | 2015-12-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170146549-A1 | ISOBARIC MASS LABELS | SRMS, PTMS, QPCTL | PRCP 821/4885SMN1; SMN2 2823/4885KMT2A 2007/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.